Prevenar 13, Injektionssuspension in einer Fertigspritze - 10 Fertigspritze(n) à 0.5 ml Swissmedic Key 60129002 Registration Holder Pfizer AG Name Prevenar 13, Injektionssuspension in einer Fertigspritze Date of registration 12.08.2010 Introduction of Sequence 12.08.2010 ATC-Classification Pneumococcus, Purified Polysaccharides Antigen Conjugated (J07AL02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.08. Show package size 10 Fertigspritze(n) à 0.5 ml Index Therapeuticus (Swissmedic) 08.08. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680601290029 Medication Code Impfstoffe Pharmacode Disponibility
Composition polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4.4 µg et polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg et polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg corresp. polysaccharida 30.8 µg et proteinum corynebacteriae diphtheriae CRM 197 ca. 32 µg, adjuvans: aluminium ut aluminii phosphas, natrii chloridum corresp. natrium 1.67 mg, acidum succinicum, polysorbatum 80, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. Packungsbestandteile Galenic Form Excipiens Active Agent Dose 2.2µg / 0.5ml 2.2µg / 0.5ml 2.2µg / 0.5ml 2.2µg / 0.5ml correspond Polysaccharida 30.8µg / 0.5ml 2.2µg / 0.5ml 4.4µg / 0.5ml 2.2µg / 0.5ml 2.2µg / 0.5ml
Inactive agents Dose additional_information Succinic Acid Alumine adjuvans 2.2µg / 0.5ml Sodium Chloride 14 Polysorbatum 80 32µg / 0.5ml
Source Data was imported : 06.04.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
